Report from the 26th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Hepatocellular and Biliary Tract Cancer, Saskatoon, Saskatchewan, 17–18 October 2024
Deepti Ravi(Saskatchewan Health Authority), Adnan Zaidi(University of Saskatchewan), Branawan Gowrishankar(University of Saskatchewan), Bryan Brunet(University of Saskatchewan), Shahid Ahmed(Emory University), Maurice Ogaick(University of Saskatchewan), Georgia Geller, Jennifer Rauw(University of Toronto), Haji Chalchal, Richard M. Lee‐Ying(Alberta Health Services), Duc Le(University of Saskatchewan), Shazia Mahmood(University of Saskatchewan), Vibhay Pareek(CancerCare Manitoba), Killian Newman(Foothills Medical Centre), Brady Anderson(University of Manitoba), Ralph Wong(CancerCare Manitoba), Vallerie Gordon(Memorial Sloan Kettering Cancer Center), Blaire Anderson(University of Alberta), Edward Hardy(Mount Vernon Cancer Centre), Mussawar Iqbal(University of Saskatchewan), Arun Elangovan, Maged N. F. Nashed(CancerCare Manitoba), Karen Mulder
Cited by 0
Related Papers
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
|New England Journal of Medicine|2008|3.6k
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
|Cancers|2023|640
Preoperative Treatment of Locally Advanced Rectal Cancer
|New England Journal of Medicine|2023|440
Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17
|European Journal of Cancer|2015|337
Gallbladder Cancer in the 21st Century
|Journal of Oncology|2015|301